Literature DB >> 23932176

End-of-life communication: a retrospective survey of representative general practitioner networks in four countries.

Natalie Evans1, Massimo Costantini2, H R Pasman3, Lieve Van den Block4, Gé A Donker5, Guido Miccinesi6, Stefano Bertolissi7, Milagros Gil8, Nicole Boffin9, Oscar Zurriaga10, Luc Deliens11, Bregje Onwuteaka-Philipsen3.   

Abstract

CONTEXT: Effective communication is central to high-quality end-of-life care.
OBJECTIVES: This study examined the prevalence of general practitioner (GP)-patient discussion of end-of-life topics (according to the GP) in Italy, Spain, Belgium, and The Netherlands and associated patient and care characteristics.
METHODS: This cross-sectional, retrospective survey was conducted with representative GP networks. Using a standardized form, GPs recorded the health and care characteristics in the last three months of life, and the discussion of 10 end-of-life topics, of all patients who died under their care. The mean number of topics discussed, the prevalence of discussion of each topic, and patient and care characteristics associated with discussions were estimated per country.
RESULTS: In total, 4396 nonsudden deaths were included. On average, more topics were discussed in The Netherlands (mean=6.37), followed by Belgium (4.45), Spain (3.32), and Italy (3.19). The topics most frequently discussed in all countries were "physical complaints" and the "primary diagnosis," whereas "spiritual and existential issues" were the least frequently discussed. Discussions were most prevalent in The Netherlands, followed by Belgium. The GPs from all countries tended to discuss fewer topics with older patients, noncancer patients, patients with dementia, patients for whom palliative care was not an important treatment aim, and patients for whom their GP had not provided palliative care.
CONCLUSION: The prevalence of end-of-life discussions varied across the four countries. In all countries, training priorities should include the identification and discussion of spiritual and social problems and early end-of-life discussions with older patients, those with cognitive decline if possible, and those with non-malignant diseases.
Copyright © 2014 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Patient-physician communication; cross-national; palliative care; patient participation; terminal illness

Mesh:

Year:  2013        PMID: 23932176     DOI: 10.1016/j.jpainsymman.2013.04.008

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  22 in total

1.  Improving palliative care provision in primary care: a pre- and post-survey evaluation among PaTz groups.

Authors:  Annicka Gm van der Plas; H Roeline W Pasman; Bart Schweitzer; Bregje D Onwuteaka-Philipsen
Journal:  Br J Gen Pract       Date:  2018-03-26       Impact factor: 5.386

2.  Poor Involvement of General Practitioners in Decisions of Withholding or Withdrawing Life-Sustaining Treatment in Emergency Departments.

Authors:  Marion Douplat; Khadidja Daoud; Julien Berthiller; Anne-Marie Schott; Véronique Potinet; Pierre Le Coz; Karim Tazarourte; Laurent Jacquin
Journal:  J Gen Intern Med       Date:  2019-11-04       Impact factor: 5.128

3.  Effectiveness of the palliative care 'Availability, Current issues and Anticipation' (ACA) communication training programme for general practitioners on patient outcomes: a controlled trial.

Authors:  Willemjan Slort; Annette H Blankenstein; Bart P M Schweitzer; Dirk L Knol; Henriëtte E van der Horst; Neil K Aaronson; Luc Deliens
Journal:  Palliat Med       Date:  2014-06-20       Impact factor: 4.762

4.  Care provided and care setting transitions in the last three months of life of cancer patients: a nationwide monitoring study in four European countries.

Authors:  Winne Ko; Luc Deliens; Guido Miccinesi; Francesco Giusti; Sarah Moreels; Gé A Donker; Bregje Onwuteaka-Philipsen; Oscar Zurriaga; Aurora López-Maside; Lieve Van den Block
Journal:  BMC Cancer       Date:  2014-12-16       Impact factor: 4.430

5.  How do treatment aims in the last phase of life relate to hospitalizations and hospital mortality? A mortality follow-back study of Dutch patients with five types of cancer.

Authors:  Mariska Oosterveld-Vlug; Gé Donker; Femke Atsma; Linda Brom; Yvonne de Man; Stef Groenewoud; Bregje Onwuteaka-Philipsen
Journal:  Support Care Cancer       Date:  2017-09-22       Impact factor: 3.603

6.  Characteristics and healthcare utilisation patterns of high-cost beneficiaries in the Netherlands: a cross-sectional claims database study.

Authors:  Joost Johan Godert Wammes; Marit Tanke; Wilma Jonkers; Gert P Westert; Philip Van der Wees; Patrick Pt Jeurissen
Journal:  BMJ Open       Date:  2017-11-12       Impact factor: 2.692

7.  Palliative care for patients with end-stage renal disease: approach to treatment that aims to improve quality of life and relieve suffering for patients (and families) with chronic illnesses.

Authors:  Amy Rak; Rupesh Raina; Theodore T Suh; Vinod Krishnappa; Jessica Darusz; Charles W Sidoti; Mona Gupta
Journal:  Clin Kidney J       Date:  2016-12-16

8.  Are older long term care residents accurately prognosticated and consequently informed about their prognosis? Results from SHELTER study data in 5 European countries.

Authors:  Maud Ten Koppel; Bregje D Onwuteaka-Philipsen; H Roeline Pasman; Roberto Bernabei; Iain Carpenter; Michael D Denkinger; Graziano Onder; Henriëtte G van der Roest; Eva Topinkova; Hein P J van Hout
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

9.  Experiences of Dutch general practitioners and district nurses with involving care services and facilities in palliative care: a mixed methods study.

Authors:  Ian Koper; H Roeline W Pasman; Bregje D Onwuteaka-Philipsen
Journal:  BMC Health Serv Res       Date:  2018-11-08       Impact factor: 2.655

10.  Palliative care delivery across health sectors: A population-level observational study.

Authors:  Peter Tanuseputro; Suman Budhwani; Yu Qing Bai; Walter P Wodchis
Journal:  Palliat Med       Date:  2016-07-10       Impact factor: 4.762

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.